Hong Kong is uniquely positioned to become a leading regional hub for longevity medicine, driven by the growing "silver economy" and proactive ageing strategies. The global longevity market is substantial and expanding rapidly, particularly in the Asia-Pacific region. By focusing on research, clinical trials, regulatory approval, and capital scaling, Hong Kong can capitalize on this trend. AI
RANK_REASON Opinion piece discussing strategic positioning for a growing market.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
